We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Wireless Smartphone Electrocardiogram Monitors Heart Health

By HospiMedica International staff writers
Posted on 26 Apr 2012
Print article
Image: The AliveCor smartphone ECG investigational medical wireless device (Photo courtesy of AliveCor).
Image: The AliveCor smartphone ECG investigational medical wireless device (Photo courtesy of AliveCor).
A credit card sized wireless device that connects to a smartphone helps physicians and health care providers obtain electrocardiograms (ECGs) to assess their patients’ cardiac health.

The AliveCor smartphone ECG is an investigational medical wireless device, which incorporates electrodes into a case that snaps onto the back of a smart phone, allowing for wireless single-lead recording of 30-second rhythm strips that are stored securely in the cloud and on the device itself. The ECGs are wirelessly downloaded for immediate interpretation using a variety of browsers. The AliveCor smartphone ECG is a product of AliveCor (Oklahoma city, OK, USA), and designed to work in conjunction with a range of mobile platforms, including the iPhone, the iPad, and Android devices.

“The implications of this technology for improving public awareness of health metrics and for early diagnosis of arrhythmias could be beneficial for physicians, their patients, and for payers,” said David Albert, MD, founder and chief medical officer of AliveCor. “Current monitoring systems for diagnosing arrhythmias are cumbersome, result in an inefficient use of health care resources, are subject to inaccuracy due to lack of patient compliance and fail to reach many patients who need better monitoring.”

In a study that examined the clinical implications of the device, 54 participants were enrolled to determine how they use the device, and were reviewed daily. After using the device, 24% of the subjects reached out to their private physicians for a consultation, and 16% felt that they discovered a health condition previously unknown to them; 75% of participants requested continuation of the device usage after the eight-week study period. In all, 33% felt that they were more health conscious after participating in the study and 88% thought that the device was transmitting accurate information. The study was presented as a poster session at the American College of Cardiology (ACC) annual scientific sessions, held during March 2012 in Chicago (IL, USA).

“The study provided us with important information required to optimize the device for physician and patient application,” said coauthor and study presenter Leslie Saxon, MD, chief of cardiovascular medicine at the University of Southern California Center for Body Computing (CBC; Los Angeles, USA). “This device incorporated into smartphones and tablets provides physicians and their patients with a clinical-quality, low cost heart monitor that will increase the global availability of advanced cardiac monitoring.”

Related Links:
AliveCor
University of Southern California Center for Body Computing

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Flocked Fiber Swabs
Puritan® patented HydraFlock®
New
Venous Vascular Closure System
VASCADE MVP
New
Air/Oxygen Blender
MicroMax

Print article

Channels

Critical Care

view channel
Image: The microfluidic chip analyzes the chemotactic migration behaviors of neutrophils in sepsis patients (Talanta, 2024; DOI: 10.1016/j.talanta.2024.126801)

Microfluidic Chip Method to Improve Sepsis Diagnosis, Progression Evaluation and Prognosis Monitoring

Sepsis, a severe and life-threatening condition, results from an uncontrolled immune response that can lead to multi-organ failure. Given its high mortality rate and the limitations of current diagnostic... Read more

Surgical Techniques

view channel
Image: Illustration of how the razor-sharp flakes of graphene line up together on a surface and can kill bacteria without harming healthy human cells (Photo courtesy of Yen Sandqvist)

Ultra-Thin Graphene-Based Coating Material Paves Way for Bacteria-Killing Medical Devices

Healthcare-associated infections are a significant global issue, leading to immense suffering, increased healthcare costs, and a greater risk of antibiotic resistance. These infections often occur when... Read more

Patient Care

view channel
Image: The portable, handheld BeamClean technology inactivates pathogens on commonly touched surfaces in seconds (Photo courtesy of Freestyle Partners)

First-Of-Its-Kind Portable Germicidal Light Technology Disinfects High-Touch Clinical Surfaces in Seconds

Reducing healthcare-acquired infections (HAIs) remains a pressing issue within global healthcare systems. In the United States alone, 1.7 million patients contract HAIs annually, leading to approximately... Read more

Point of Care

view channel
The Atellica VTLi Patient-side Immunoassay Analyzer, a high-sensitivity troponin I test at the bedside, delivers accurate results in just 8 minutes (Photo courtesy of Siemens Healthineers)

New 8-Minute Blood Test to Diagnose or Rule Out Heart Attack Shortens ED Stay

Emergency department overcrowding is a significant global issue that leads to increased mortality and morbidity, with chest pain being one of the most common reasons for hospital admissions.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.